Evidence map›Paper›PMID 30510445›Full record

ArticleJournal of pain research2018

Efficacy of isothiocyanate-based compounds on different forms of persistent pain.

Elena Lucarini, Laura Micheli, Alma Martelli, Lara Testai, Vincenzo Calderone, Carla Ghelardini, Lorenzo Di Cesare Mannelli

Open access · goldAbstract read
In one paragraph

Article in Journal of pain research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. HJournal of molecular neuroscience : MN · 2023
    Article
  5. The Efficacy ofNutrients · 2022
    Article
  6. Beneficial Effects ofFoods (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elena LucariniPharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research, and Child Health (Neurofarba), University of Florence, Florence, Italy, lorenzo.mannelli@unifi.it.
Laura MicheliPharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research, and Child Health (Neurofarba), University of Florence, Florence, Italy, lorenzo.mannelli@unifi.it.
Alma MartelliDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Lara TestaiDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Vincenzo CalderoneDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Carla GhelardiniPharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research, and Child Health (Neurofarba), University of Florence, Florence, Italy, lorenzo.mannelli@unifi.it.
Lorenzo Di Cesare MannelliPharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research, and Child Health (Neurofarba), University of Florence, Florence, Italy, lorenzo.mannelli@unifi.it.
University of Florence · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCurrent pharmacotherapy for persistent pain related to neuropathy or articular diseases is unsatisfactory, due to the large number of unresponsive patients and side effects. Isothiocyanates (ITCs) are a class of natural or synthetic compounds characterized by the general formula R-NCS. ITCs show antihyperalgesic effects in models of central and peripheral nervous tissue injury and anti-inflammatory properties. The pharmacodynamics are strictly related to the release of the gasotransmitter hydrogen sulfide (H

methodsNerve injury and osteoarthritis were induced in rats by ligation of the sciatic nerve (chronic constriction injury) and intra-articular injection of monoiodoacetate, respectively. Behavioral tests were performed 14 days after damage induction.

resultsSingle subcutaneous administrations of PITC, 3C-PITC (4.43 and 13.31 µmol kg

conclusionITCs offer a promising novel approach to counteract persistent, drug-resistant painful pathology.

Indexed as

H2Sisothiocyanatenerve injuryneuropathic painosteoarthritis

Identifiers

PMID30510445
PMCPMC6250104
OpenAlexW2901799135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.